Skip to main content
FinSpry Logo
FinSpry
HUMA logo
HUMA
(NASDAQ)
Humacyte, Inc.
$0.64-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Humacyte (HUMA) Stock Price & Financial Analysis

Humacyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.58 - $0.66
52-Week High$2.93
52-Week Low$0.55
Open$0.58
Volume4.71M
Average Volume (3M)4.71M
Market Cap101.70M
Shares Outstanding158.31M
Price to Sales (P/S)10.65
EV/EBITDA-5.49
Revenue (TTM)8.80M
Net Income (TTM)-36.97M
Free Cash Flow (TTM)-106.40M
EPS (TTM)$-0.23
Profit Margin-420.15%
Operating Margin-1197.74%
50-Day MA$1.01
200-Day MA$1.51
52-Week Change-60.28%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Humacyte

What is the current stock price for HUMA?

As of the latest trading session, HUMA stock trades at $0.64. The 52-week range is $0.55–$2.93, with a day range of $0.57–$0.66.

What is the P/E ratio for HUMA?

The P/E ratio (Price-to-Earnings) for HUMA is shown in the Key Statistics section. This valuation metric helps compare Humacyte, Inc. to industry peers.

Does HUMA pay dividends?

Humacyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HUMA?

Based on 5 analysts, the consensus for HUMA is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of HUMA?

Humacyte's market capitalization is $101.7M, classifying it as a micro-cap company. Humacyte operates in the Healthcare sector within the Biotechnology industry.